Last reviewed · How we verify

NCT04872374

Effects of Parmigiano Reggiano on Skeletal Muscle Damage in Older Adults

Status unknown NA Last updated 4 May 2021
What this trial tests

NA trial testing Parmigiano Reggiano in Old Age; Atrophy in 20 participants. Status unknown.

Timeline
1 May 2021
Primary endpoint
31 October 2021
1 March 2022

Quick facts

Lead sponsorUniversity of Padova
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 May 2021
Primary completion31 October 2021
Estimated completion1 March 2022
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Padova

Who can join

18 and older, any sex, with Old Age; Atrophy or Inflammatory Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aging is associated with the loss of muscle mass and function (sarcopenia) and reduced tissue regenerative capacity. Eccentric exercise (ECC) is a model of RET that can be used with the elderly, due to the ability of the muscle to combine high muscle strength production with low energy cost. ECC contractions are significantly more damaging to the muscles and produce greater muscle strength, for these reasons there is a greater risk of inducing muscle damage before the muscle is able to adapt. Parmigiano Reggiano (PR) has some peculiar bromatological characteristics. The proteins contained in it, and in particular the potentially bioactive peptide sequences, can rapidly provide the amino acids necessary to promote muscle growth and repair during exercise. Furthermore, PR can be an important source of fatty acids, of which a significant amount of short-chain fatty acids (SCFA) which are known to have important clinical effects on body composition and metabolic health and can have a systemic anti-inflammatory effect. Therefore, the central hypothes is that PR consumed during RET can provide more energy substrates and improve muscle recovery. To date, no studies have studied its function on recovery from exercise nor in the elderly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Parmigiano Reggiano

Trials testing the same drug.

Other recruiting trials for Old Age; Atrophy

Currently open trials in the same condition.

Other University of Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04872374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing